new BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 124 hits Enz. Inhib. hit(s) with all data for entry = 7646   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM208981
PNG
((4R,4aR,7S,7aR,12bS)-3-methyl-2,3,4,4a,7,7a-hexahy...)
Show SMILES CO[C@H]1C=CC2C3Cc4ccc(O)c5OC1[C@]2(CCN3C)c45 |r,c:3,TLB:13:21:5:19.17.18,9:8:5:19.17.18|
Show InChI InChI=1/C18H21NO3/c1-19-8-7-18-11-4-6-14(21-2)17(18)22-16-13(20)5-3-10(15(16)18)9-12(11)19/h3-6,11-12,14,17,20H,7-9H2,1-2H3/t11?,12?,14-,17?,18-/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
8.44 -46.1n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM50105085
PNG
(17-cyclobutylmethyl-4,5alpha-epoxymorphinan-3,6alp...)
Show SMILES O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CCC1)c45 |r|
Show InChI InChI=1S/C21H27NO4/c23-14-5-4-13-10-16-21(25)7-6-15(24)19-20(21,17(13)18(14)26-19)8-9-22(16)11-12-2-1-3-12/h4-5,12,15-16,19,23-25H,1-3,6-11H2/t15-,16+,19-,20-,21+/m0/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
Purchase

CHEMBL
DrugBank
KEGG
PC cid
PC sid
UniChem

Patents

US Patent
14.3n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM208982
PNG
(US9233167, a-6-mPEG1-O-Morphine)
Show SMILES COCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3C)c45 |r,TLB:17:25:8:23.21.22,13:12:8:23.21.22|
Show InChI InChI=1/C20H27NO5/c1-21-8-7-19-16-12-3-4-13(22)17(16)26-18(19)14(25-10-9-24-2)5-6-20(19,23)15(21)11-12/h3-4,14-15,18,22-23H,5-11H2,1-2H3/t14-,15?,18-,19-,20+/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
15.7 -44.5n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM209007
PNG
(US9233167, 6-O-mPEG4-Nalbuphine)
Show SMILES COCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 |r,TLB:16:17:20.21.38:32.30.31,THB:18:17:20.21.38:32.30.31|
Show InChI InChI=1/C30H45NO8/c1-34-11-12-35-13-14-36-15-16-37-17-18-38-24-7-8-30(33)25-19-22-5-6-23(32)27-26(22)29(30,28(24)39-27)9-10-31(25)20-21-3-2-4-21/h5-6,21,24-25,28,32-33H,2-4,7-20H2,1H3/t24-,25+,28?,29-,30+/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
17.5n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM208983
PNG
(US9233167, a-6-mPEG2-O-Morphine)
Show SMILES COCCOCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3C)c45 |r,TLB:20:28:11:26.24.25,16:15:11:26.24.25|
Show InChI InChI=1/C22H31NO6/c1-23-8-7-21-18-14-3-4-15(24)19(18)29-20(21)16(28-12-11-27-10-9-26-2)5-6-22(21,25)17(23)13-14/h3-4,16-17,20,24-25H,5-13H2,1-2H3/t16-,17?,20-,21-,22+/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
22.0 -43.7n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM208985
PNG
(US9233167, a-6-mPEG4-O-Morphine)
Show SMILES COCCOCCOCCOCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3C)c45 |r,TLB:26:34:17:32.30.31,22:21:17:32.30.31|
Show InChI InChI=1/C26H39NO8/c1-27-8-7-25-22-18-3-4-19(28)23(22)35-24(25)20(5-6-26(25,29)21(27)17-18)34-16-15-33-14-13-32-12-11-31-10-9-30-2/h3-4,20-21,24,28-29H,5-17H2,1-2H3/t20-,21?,24-,25-,26+/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
23.1 -43.6n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM208977
PNG
(US9233167, 6-O-mPEG3-Nalbuphine)
Show SMILES COCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 |r,TLB:13:14:17.18.35:29.27.28,THB:15:14:17.18.35:29.27.28|
Show InChI InChI=1/C28H41NO7/c1-32-11-12-33-13-14-34-15-16-35-22-7-8-28(31)23-17-20-5-6-21(30)25-24(20)27(28,26(22)36-25)9-10-29(23)18-19-3-2-4-19/h5-6,19,22-23,26,30-31H,2-4,7-18H2,1H3/t22-,23+,26?,27-,28+/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
27.4n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Opioid receptors; mu/kappa/delta


(Homo sapiens (Human))
BDBM50105085
PNG
(17-cyclobutylmethyl-4,5alpha-epoxymorphinan-3,6alp...)
Show SMILES O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CCC1)c45 |r|
Show InChI InChI=1S/C21H27NO4/c23-14-5-4-13-10-16-21(25)7-6-15(24)19-20(21,17(13)18(14)26-19)8-9-22(16)11-12-2-1-3-12/h4-5,12,15-16,19,23-25H,1-3,6-11H2/t15-,16+,19-,20-,21+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
Purchase

CHEMBL
DrugBank
KEGG
PC cid
PC sid
UniChem

Patents

US Patent
29.9n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM209008
PNG
(US9233167, 6-O-mPEG5-Nalbuphine)
Show SMILES COCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 |r,TLB:19:20:23.24.41:35.33.34,THB:21:20:23.24.41:35.33.34|
Show InChI InChI=1/C32H49NO9/c1-36-11-12-37-13-14-38-15-16-39-17-18-40-19-20-41-26-7-8-32(35)27-21-24-5-6-25(34)29-28(24)31(32,30(26)42-29)9-10-33(27)22-23-3-2-4-23/h5-6,23,26-27,30,34-35H,2-4,7-22H2,1H3/t26-,27+,30?,31-,32+/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
35.1n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Opioid receptors; mu/kappa/delta


(Homo sapiens (Human))
BDBM209008
PNG
(US9233167, 6-O-mPEG5-Nalbuphine)
Show SMILES COCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 |r,TLB:19:20:23.24.41:35.33.34,THB:21:20:23.24.41:35.33.34|
Show InChI InChI=1/C32H49NO9/c1-36-11-12-37-13-14-38-15-16-39-17-18-40-19-20-41-26-7-8-32(35)27-21-24-5-6-25(34)29-28(24)31(32,30(26)42-29)9-10-33(27)22-23-3-2-4-23/h5-6,23,26-27,30,34-35H,2-4,7-22H2,1H3/t26-,27+,30?,31-,32+/s2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
35.6n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM208986
PNG
(US9233167, a-6-mPEG5-O-Morphine)
Show SMILES COCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3C)c45 |r,TLB:29:37:20:35.33.34,25:24:20:35.33.34|
Show InChI InChI=1/C28H43NO9/c1-29-8-7-27-24-20-3-4-21(30)25(24)38-26(27)22(5-6-28(27,31)23(29)19-20)37-18-17-36-16-15-35-14-13-34-12-11-33-10-9-32-2/h3-4,22-23,26,30-31H,5-19H2,1-2H3/t22-,23?,26-,27-,28+/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
39.4 -42.3n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM208978
PNG
(US9233167, 6-O-mPEG6-Nalbuphine)
Show SMILES COCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 |r,TLB:22:23:26.27.44:38.36.37,THB:24:23:26.27.44:38.36.37|
Show InChI InChI=1/C34H53NO10/c1-38-11-12-39-13-14-40-15-16-41-17-18-42-19-20-43-21-22-44-28-7-8-34(37)29-23-26-5-6-27(36)31-30(26)33(34,32(28)45-31)9-10-35(29)24-25-3-2-4-25/h5-6,25,28-29,32,36-37H,2-4,7-24H2,1H3/t28-,29+,32?,33-,34+/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
44.3n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM208984
PNG
(US9233167, a-6-mPEG3-O-Morphine)
Show SMILES COCCOCCOCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3C)c45 |r,TLB:23:31:14:29.27.28,19:18:14:29.27.28|
Show InChI InChI=1/C24H35NO7/c1-25-8-7-23-20-16-3-4-17(26)21(20)32-22(23)18(5-6-24(23,27)19(25)15-16)31-14-13-30-12-11-29-10-9-28-2/h3-4,18-19,22,26-27H,5-15H2,1-2H3/t18-,19?,22-,23-,24+/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
50.7 -41.6n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM208988
PNG
(US9233167, a-6-mPEG7-O-Morphine)
Show SMILES COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3C)c45 |r,TLB:35:43:26:41.39.40,31:30:26:41.39.40|
Show InChI InChI=1/C32H51NO11/c1-33-8-7-31-28-24-3-4-25(34)29(28)44-30(31)26(5-6-32(31,35)27(33)23-24)43-22-21-42-20-19-41-18-17-40-16-15-39-14-13-38-12-11-37-10-9-36-2/h3-4,26-27,30,34-35H,5-23H2,1-2H3/t26-,27?,30-,31-,32+/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
56.9 -41.4n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM208987
PNG
(US9233167, a-6-mPEG6-O-Morphine)
Show SMILES COCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3C)c45 |r,TLB:32:40:23:38.36.37,28:27:23:38.36.37|
Show InChI InChI=1/C30H47NO10/c1-31-8-7-29-26-22-3-4-23(32)27(26)41-28(29)24(5-6-30(29,33)25(31)21-22)40-20-19-39-18-17-38-16-15-37-14-13-36-12-11-35-10-9-34-2/h3-4,24-25,28,32-33H,5-21H2,1-2H3/t24-,25?,28-,29-,30+/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
73.0 -40.7n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM209010
PNG
(US9233167, 6-O-mPEG7-Nalbuphine)
Show SMILES COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 |r,TLB:25:26:29.30.47:41.39.40,THB:27:26:29.30.47:41.39.40|
Show InChI InChI=1/C36H57NO11/c1-40-11-12-41-13-14-42-15-16-43-17-18-44-19-20-45-21-22-46-23-24-47-30-7-8-36(39)31-25-28-5-6-29(38)33-32(28)35(36,34(30)48-33)9-10-37(31)26-27-3-2-4-27/h5-6,27,30-31,34,38-39H,2-4,7-26H2,1H3/t30-,31+,34?,35-,36+/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
77.9n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM209009
PNG
(US9233167, 6-O-mPEG8-Nalbuphine)
Show SMILES COCCOCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 |r,TLB:28:29:32.33.50:44.42.43,THB:30:29:32.33.50:44.42.43|
Show InChI InChI=1/C38H61NO12/c1-42-11-12-43-13-14-44-15-16-45-17-18-46-19-20-47-21-22-48-23-24-49-25-26-50-32-7-8-38(41)33-27-30-5-6-31(40)35-34(30)37(38,36(32)51-35)9-10-39(33)28-29-3-2-4-29/h5-6,29,32-33,36,40-41H,2-4,7-28H2,1H3/t32-,33+,36?,37-,38+/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
79.5n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM208989
PNG
(US9233167, a-6-mPEG9-O-Morphine)
Show SMILES COCCOCCOCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3C)c45 |r,TLB:41:49:32:47.45.46,37:36:32:47.45.46|
Show InChI InChI=1/C36H59NO13/c1-37-8-7-35-32-28-3-4-29(38)33(32)50-34(35)30(5-6-36(35,39)31(37)27-28)49-26-25-48-24-23-47-22-21-46-20-19-45-18-17-44-16-15-43-14-13-42-12-11-41-10-9-40-2/h3-4,30-31,34,38-39H,5-27H2,1-2H3/t30-,31?,34-,35-,36+/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
111 -39.7n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Opioid receptors; mu/kappa/delta


(Homo sapiens (Human))
BDBM208981
PNG
((4R,4aR,7S,7aR,12bS)-3-methyl-2,3,4,4a,7,7a-hexahy...)
Show SMILES CO[C@H]1C=CC2C3Cc4ccc(O)c5OC1[C@]2(CCN3C)c45 |r,c:3,TLB:13:21:5:19.17.18,9:8:5:19.17.18|
Show InChI InChI=1/C18H21NO3/c1-19-8-7-18-11-4-6-14(21-2)17(18)22-16-13(20)5-3-10(15(16)18)9-12(11)19/h3-6,11-12,14,17,20H,7-9H2,1-2H3/t11?,12?,14-,17?,18-/s2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
118 -39.5n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM208979
PNG
(US9233167, 6-O-mPEG9-Nalbuphine)
Show SMILES COCCOCCOCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 |r,TLB:31:32:35.36.53:47.45.46,THB:33:32:35.36.53:47.45.46|
Show InChI InChI=1/C40H65NO13/c1-44-11-12-45-13-14-46-15-16-47-17-18-48-19-20-49-21-22-50-23-24-51-25-26-52-27-28-53-34-7-8-40(43)35-29-32-5-6-33(42)37-36(32)39(40,38(34)54-37)9-10-41(35)30-31-3-2-4-31/h5-6,31,34-35,38,42-43H,2-4,7-30H2,1H3/t34-,35+,38?,39-,40+/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
122n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Delta-type opioid receptor


(Homo sapiens (Human))
BDBM208978
PNG
(US9233167, 6-O-mPEG6-Nalbuphine)
Show SMILES COCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 |r,TLB:22:23:26.27.44:38.36.37,THB:24:23:26.27.44:38.36.37|
Show InChI InChI=1/C34H53NO10/c1-38-11-12-39-13-14-40-15-16-41-17-18-42-19-20-43-21-22-44-28-7-8-34(37)29-23-26-5-6-27(36)31-30(26)33(34,32(28)45-31)9-10-35(29)24-25-3-2-4-25/h5-6,25,28-29,32,36-37H,2-4,7-24H2,1H3/t28-,29+,32?,33-,34+/s2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
130n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM50370595
PNG
(OXYCODONE | Oxycontin | US9233167, Oxycodone)
Show SMILES COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O |TLB:20:21:16.5.6:8.11.10,THB:22:21:16.5.6:8.11.10|
Show InChI InChI=1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3/t13-,16+,17+,18-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
Purchase

DrugBank
KEGG
PC cid
PC sid
UniChem
US Patent
133 -39.2n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Delta-type opioid receptor


(Homo sapiens (Human))
BDBM209008
PNG
(US9233167, 6-O-mPEG5-Nalbuphine)
Show SMILES COCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 |r,TLB:19:20:23.24.41:35.33.34,THB:21:20:23.24.41:35.33.34|
Show InChI InChI=1/C32H49NO9/c1-36-11-12-37-13-14-38-15-16-39-17-18-40-19-20-41-26-7-8-32(35)27-21-24-5-6-25(34)29-28(24)31(32,30(26)42-29)9-10-33(27)22-23-3-2-4-23/h5-6,23,26-27,30,34-35H,2-4,7-22H2,1H3/t26-,27+,30?,31-,32+/s2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
148n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Delta-type opioid receptor


(Homo sapiens (Human))
BDBM209007
PNG
(US9233167, 6-O-mPEG4-Nalbuphine)
Show SMILES COCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 |r,TLB:16:17:20.21.38:32.30.31,THB:18:17:20.21.38:32.30.31|
Show InChI InChI=1/C30H45NO8/c1-34-11-12-35-13-14-36-15-16-37-17-18-38-24-7-8-30(33)25-19-22-5-6-23(32)27-26(22)29(30,28(24)39-27)9-10-31(25)20-21-3-2-4-21/h5-6,21,24-25,28,32-33H,2-4,7-20H2,1H3/t24-,25+,28?,29-,30+/s2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
149n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Delta-type opioid receptor


(Homo sapiens (Human))
BDBM208979
PNG
(US9233167, 6-O-mPEG9-Nalbuphine)
Show SMILES COCCOCCOCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 |r,TLB:31:32:35.36.53:47.45.46,THB:33:32:35.36.53:47.45.46|
Show InChI InChI=1/C40H65NO13/c1-44-11-12-45-13-14-46-15-16-47-17-18-48-19-20-49-21-22-50-23-24-51-25-26-52-27-28-53-34-7-8-40(43)35-29-32-5-6-33(42)37-36(32)39(40,38(34)54-37)9-10-41(35)30-31-3-2-4-31/h5-6,31,34-35,38,42-43H,2-4,7-30H2,1H3/t34-,35+,38?,39-,40+/s2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
158n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Delta-type opioid receptor


(Homo sapiens (Human))
BDBM208977
PNG
(US9233167, 6-O-mPEG3-Nalbuphine)
Show SMILES COCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 |r,TLB:13:14:17.18.35:29.27.28,THB:15:14:17.18.35:29.27.28|
Show InChI InChI=1/C28H41NO7/c1-32-11-12-33-13-14-34-15-16-35-22-7-8-28(31)23-17-20-5-6-21(30)25-24(20)27(28,26(22)36-25)9-10-29(23)18-19-3-2-4-19/h5-6,19,22-23,26,30-31H,2-4,7-18H2,1H3/t22-,23+,26?,27-,28+/s2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
163n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Delta-type opioid receptor


(Homo sapiens (Human))
BDBM209009
PNG
(US9233167, 6-O-mPEG8-Nalbuphine)
Show SMILES COCCOCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 |r,TLB:28:29:32.33.50:44.42.43,THB:30:29:32.33.50:44.42.43|
Show InChI InChI=1/C38H61NO12/c1-42-11-12-43-13-14-44-15-16-45-17-18-46-19-20-47-21-22-48-23-24-49-25-26-50-32-7-8-38(41)33-27-30-5-6-31(40)35-34(30)37(38,36(32)51-35)9-10-39(33)28-29-3-2-4-29/h5-6,29,32-33,36,40-41H,2-4,7-28H2,1H3/t32-,33+,36?,37-,38+/s2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
168n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Opioid receptors; mu/kappa/delta


(Homo sapiens (Human))
BDBM208979
PNG
(US9233167, 6-O-mPEG9-Nalbuphine)
Show SMILES COCCOCCOCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 |r,TLB:31:32:35.36.53:47.45.46,THB:33:32:35.36.53:47.45.46|
Show InChI InChI=1/C40H65NO13/c1-44-11-12-45-13-14-46-15-16-47-17-18-48-19-20-49-21-22-50-23-24-51-25-26-52-27-28-53-34-7-8-40(43)35-29-32-5-6-33(42)37-36(32)39(40,38(34)54-37)9-10-41(35)30-31-3-2-4-31/h5-6,31,34-35,38,42-43H,2-4,7-30H2,1H3/t34-,35+,38?,39-,40+/s2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
186n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Opioid receptors; mu/kappa/delta


(Homo sapiens (Human))
BDBM208977
PNG
(US9233167, 6-O-mPEG3-Nalbuphine)
Show SMILES COCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 |r,TLB:13:14:17.18.35:29.27.28,THB:15:14:17.18.35:29.27.28|
Show InChI InChI=1/C28H41NO7/c1-32-11-12-33-13-14-34-15-16-35-22-7-8-28(31)23-17-20-5-6-21(30)25-24(20)27(28,26(22)36-25)9-10-29(23)18-19-3-2-4-19/h5-6,19,22-23,26,30-31H,2-4,7-18H2,1H3/t22-,23+,26?,27-,28+/s2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
218n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Opioid receptors; mu/kappa/delta


(Homo sapiens (Human))
BDBM208978
PNG
(US9233167, 6-O-mPEG6-Nalbuphine)
Show SMILES COCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 |r,TLB:22:23:26.27.44:38.36.37,THB:24:23:26.27.44:38.36.37|
Show InChI InChI=1/C34H53NO10/c1-38-11-12-39-13-14-40-15-16-41-17-18-42-19-20-43-21-22-44-28-7-8-34(37)29-23-26-5-6-27(36)31-30(26)33(34,32(28)45-31)9-10-35(29)24-25-3-2-4-25/h5-6,25,28-29,32,36-37H,2-4,7-24H2,1H3/t28-,29+,32?,33-,34+/s2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
247n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Opioid receptors; mu/kappa/delta


(Homo sapiens (Human))
BDBM209009
PNG
(US9233167, 6-O-mPEG8-Nalbuphine)
Show SMILES COCCOCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 |r,TLB:28:29:32.33.50:44.42.43,THB:30:29:32.33.50:44.42.43|
Show InChI InChI=1/C38H61NO12/c1-42-11-12-43-13-14-44-15-16-45-17-18-46-19-20-47-21-22-48-23-24-49-25-26-50-32-7-8-38(41)33-27-30-5-6-31(40)35-34(30)37(38,36(32)51-35)9-10-39(33)28-29-3-2-4-29/h5-6,29,32-33,36,40-41H,2-4,7-28H2,1H3/t32-,33+,36?,37-,38+/s2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
282n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Delta-type opioid receptor


(Homo sapiens (Human))
BDBM209010
PNG
(US9233167, 6-O-mPEG7-Nalbuphine)
Show SMILES COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 |r,TLB:25:26:29.30.47:41.39.40,THB:27:26:29.30.47:41.39.40|
Show InChI InChI=1/C36H57NO11/c1-40-11-12-41-13-14-42-15-16-43-17-18-44-19-20-45-21-22-46-23-24-47-30-7-8-36(39)31-25-28-5-6-29(38)33-32(28)35(36,34(30)48-33)9-10-37(31)26-27-3-2-4-27/h5-6,27,30-31,34,38-39H,2-4,7-26H2,1H3/t30-,31+,34?,35-,36+/s2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
314n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Delta-type opioid receptor


(Homo sapiens (Human))
BDBM50105085
PNG
(17-cyclobutylmethyl-4,5alpha-epoxymorphinan-3,6alp...)
Show SMILES O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CCC1)c45 |r|
Show InChI InChI=1S/C21H27NO4/c23-14-5-4-13-10-16-21(25)7-6-15(24)19-20(21,17(13)18(14)26-19)8-9-22(16)11-12-2-1-3-12/h4-5,12,15-16,19,23-25H,1-3,6-11H2/t15-,16+,19-,20-,21+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
Purchase

CHEMBL
DrugBank
KEGG
PC cid
PC sid
UniChem

Patents

US Patent
319n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Opioid receptors; mu/kappa/delta


(Homo sapiens (Human))
BDBM209010
PNG
(US9233167, 6-O-mPEG7-Nalbuphine)
Show SMILES COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 |r,TLB:25:26:29.30.47:41.39.40,THB:27:26:29.30.47:41.39.40|
Show InChI InChI=1/C36H57NO11/c1-40-11-12-41-13-14-42-15-16-43-17-18-44-19-20-45-21-22-46-23-24-47-30-7-8-36(39)31-25-28-5-6-29(38)33-32(28)35(36,34(30)48-33)9-10-37(31)26-27-3-2-4-27/h5-6,27,30-31,34,38-39H,2-4,7-26H2,1H3/t30-,31+,34?,35-,36+/s2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
346n/an/an/an/an/an/an/an/a



Nektar Therapeutics

US Patent


Assay Description
Specific binding is determined by subtraction of the cpm bound in the presence of 50-100 excess of cold ligand. Binding data assays were analyzed us...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Opioid receptors; mu/kappa/delta


(Homo sapiens (Human))
BDBM208983
PNG
(US9233167, a-6-mPEG2-O-Morphine)
Show SMILES COCCOCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3C)c45 |r,TLB:20:28:11:26.24.25,16:15:11:26.24.25|
Show InChI InChI=1/C22H31NO6/c1-23-8-7-21-18-14-3-4-15(24)19(18)29-20(21)16(28-12-11-27-10-9-26-2)5-6-22(21,25)17(23)13-14/h3-4,16-17,20,24-25H,5-13H2,1-2H3/t16-,17?,20-,21-,22+/s2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
404 -36.5n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Opioid receptors; mu/kappa/delta


(Homo sapiens (Human))
BDBM208985
PNG
(US9233167, a-6-mPEG4-O-Morphine)
Show SMILES COCCOCCOCCOCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3C)c45 |r,TLB:26:34:17:32.30.31,22:21:17:32.30.31|
Show InChI InChI=1/C26H39NO8/c1-27-8-7-25-22-18-3-4-19(28)23(22)35-24(25)20(5-6-26(25,29)21(27)17-18)34-16-15-33-14-13-32-12-11-31-10-9-30-2/h3-4,20-21,24,28-29H,5-17H2,1-2H3/t20-,21?,24-,25-,26+/s2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
439 -36.3n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Opioid receptors; mu/kappa/delta


(Homo sapiens (Human))
BDBM208982
PNG
(US9233167, a-6-mPEG1-O-Morphine)
Show SMILES COCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3C)c45 |r,TLB:17:25:8:23.21.22,13:12:8:23.21.22|
Show InChI InChI=1/C20H27NO5/c1-21-8-7-19-16-12-3-4-13(22)17(16)26-18(19)14(25-10-9-24-2)5-6-20(19,23)15(21)11-12/h3-4,14-15,18,22-23H,5-11H2,1-2H3/t14-,15?,18-,19-,20+/s2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
445 -36.3n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Opioid receptors; mu/kappa/delta


(Homo sapiens (Human))
BDBM208986
PNG
(US9233167, a-6-mPEG5-O-Morphine)
Show SMILES COCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3C)c45 |r,TLB:29:37:20:35.33.34,25:24:20:35.33.34|
Show InChI InChI=1/C28H43NO9/c1-29-8-7-27-24-20-3-4-21(30)25(24)38-26(27)22(5-6-28(27,31)23(29)19-20)37-18-17-36-16-15-35-14-13-34-12-11-33-10-9-32-2/h3-4,22-23,26,30-31H,5-19H2,1-2H3/t22-,23?,26-,27-,28+/s2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
558 -35.7n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Opioid receptors; mu/kappa/delta


(Homo sapiens (Human))
BDBM208984
PNG
(US9233167, a-6-mPEG3-O-Morphine)
Show SMILES COCCOCCOCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3C)c45 |r,TLB:23:31:14:29.27.28,19:18:14:29.27.28|
Show InChI InChI=1/C24H35NO7/c1-25-8-7-23-20-16-3-4-17(26)21(20)32-22(23)18(5-6-24(23,27)19(25)15-16)31-14-13-30-12-11-29-10-9-28-2/h3-4,18-19,22,26-27H,5-15H2,1-2H3/t18-,19?,22-,23-,24+/s2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
576 -35.6n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM208991
PNG
(US9233167, a-6-mPEG2-O-Hydroxycodone)
Show SMILES COCCOCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(OC)c5O[C@@H]1[C@]2(CCN3C)c45 |r,TLB:21:29:11:27.25.26,16:15:11:27.25.26|
Show InChI InChI=1/C23H33NO6/c1-24-9-8-22-19-15-4-5-16(27-3)20(19)30-21(22)17(29-13-12-28-11-10-26-2)6-7-23(22,25)18(24)14-15/h4-5,17-18,21,25H,6-14H2,1-3H3/t17-,18?,21-,22-,23+/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
632 -35.4n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM208990
PNG
(US9233167, a-6-mPEG1-O-Hydroxycodone)
Show SMILES COCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(OC)c5O[C@@H]1[C@]2(CCN3C)c45 |r,TLB:18:26:8:24.22.23,13:12:8:24.22.23|
Show InChI InChI=1/C21H29NO5/c1-22-9-8-20-17-13-4-5-14(25-3)18(17)27-19(20)15(26-11-10-24-2)6-7-21(20,23)16(22)12-13/h4-5,15-16,19,23H,6-12H2,1-3H3/t15-,16?,19-,20-,21+/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
654 -35.3n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Opioid receptors; mu/kappa/delta


(Homo sapiens (Human))
BDBM208988
PNG
(US9233167, a-6-mPEG7-O-Morphine)
Show SMILES COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3C)c45 |r,TLB:35:43:26:41.39.40,31:30:26:41.39.40|
Show InChI InChI=1/C32H51NO11/c1-33-8-7-31-28-24-3-4-25(34)29(28)44-30(31)26(5-6-32(31,35)27(33)23-24)43-22-21-42-20-19-41-18-17-40-16-15-39-14-13-38-12-11-37-10-9-36-2/h3-4,26-27,30,34-35H,5-23H2,1-2H3/t26-,27?,30-,31-,32+/s2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
670 -35.2n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Opioid receptors; mu/kappa/delta


(Homo sapiens (Human))
BDBM208987
PNG
(US9233167, a-6-mPEG6-O-Morphine)
Show SMILES COCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3C)c45 |r,TLB:32:40:23:38.36.37,28:27:23:38.36.37|
Show InChI InChI=1/C30H47NO10/c1-31-8-7-29-26-22-3-4-23(32)27(26)41-28(29)24(5-6-30(29,33)25(31)21-22)40-20-19-39-18-17-38-16-15-37-14-13-36-12-11-35-10-9-34-2/h3-4,24-25,28,32-33H,5-21H2,1-2H3/t24-,25?,28-,29-,30+/s2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
774 -34.9n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM208992
PNG
(US9233167, a-6-mPEG3-O-Hydroxycodone)
Show SMILES COCCOCCOCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(OC)c5O[C@@H]1[C@]2(CCN3C)c45 |r,TLB:24:32:14:30.28.29,19:18:14:30.28.29|
Show InChI InChI=1/C25H37NO7/c1-26-9-8-24-21-17-4-5-18(29-3)22(21)33-23(24)19(6-7-25(24,27)20(26)16-17)32-15-14-31-13-12-30-11-10-28-2/h4-5,19-20,23,27H,6-16H2,1-3H3/t19-,20?,23-,24-,25+/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
775 -34.9n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM208993
PNG
(US9233167, a-6-mPEG4-O-Hydroxycodone)
Show SMILES COCCOCCOCCOCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(OC)c5O[C@@H]1[C@]2(CCN3C)c45 |r,TLB:27:35:17:33.31.32,22:21:17:33.31.32|
Show InChI InChI=1/C27H41NO8/c1-28-9-8-26-23-19-4-5-20(31-3)24(23)36-25(26)21(6-7-27(26,29)22(28)18-19)35-17-16-34-15-14-33-13-12-32-11-10-30-2/h4-5,21-22,25,29H,6-18H2,1-3H3/t21-,22?,25-,26-,27+/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
893 -34.5n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Opioid receptors; mu/kappa/delta


(Homo sapiens (Human))
BDBM208989
PNG
(US9233167, a-6-mPEG9-O-Morphine)
Show SMILES COCCOCCOCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3C)c45 |r,TLB:41:49:32:47.45.46,37:36:32:47.45.46|
Show InChI InChI=1/C36H59NO13/c1-37-8-7-35-32-28-3-4-29(38)33(32)50-34(35)30(5-6-36(35,39)31(37)27-28)49-26-25-48-24-23-47-22-21-46-20-19-45-18-17-44-16-15-43-14-13-42-12-11-41-10-9-40-2/h3-4,30-31,34,38-39H,5-27H2,1-2H3/t30-,31?,34-,35-,36+/s2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
1.25E+3 -33.7n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM208999
PNG
(US9233167, a-6-mPEG2-O-Codeine)
Show SMILES COCCOCCO[C@H]1C=CC2C3Cc4ccc(OC)c5OC1[C@]2(CCN3C)c45 |r,c:9,TLB:20:28:11:26.24.25,15:14:11:26.24.25|
Show InChI InChI=1/C23H31NO5/c1-24-9-8-23-16-5-7-19(28-13-12-27-11-10-25-2)22(23)29-21-18(26-3)6-4-15(20(21)23)14-17(16)24/h4-7,16-17,19,22H,8-14H2,1-3H3/t16?,17?,19-,22?,23-/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
1.38E+3 -33.4n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM208996
PNG
(US9233167, a-6-mPEG5-O-Hydroxycodone)
Show SMILES COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(OC)c5O[C@@H]1[C@]2(CCN3C)c45 |r,TLB:36:44:26:42.40.41,31:30:26:42.40.41|
Show InChI InChI=1/C33H53NO11/c1-34-9-8-32-29-25-4-5-26(37-3)30(29)45-31(32)27(6-7-33(32,35)28(34)24-25)44-23-22-43-21-20-42-19-18-41-17-16-40-15-14-39-13-12-38-11-10-36-2/h4-5,27-28,31,35H,6-24H2,1-3H3/t27-,28?,31-,32-,33+/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
1.61E+3 -33.1n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM208980
PNG
(US9233167, a-6-mPEG1-O-Codeine)
Show SMILES COCCO[C@H]1C=CC2C3Cc4ccc(OC)c5OC1[C@]2(CCN3C)c45 |r,c:6,TLB:17:25:8:23.21.22,12:11:8:23.21.22|
Show InChI InChI=1/C21H27NO4/c1-22-9-8-21-14-5-7-17(25-11-10-23-2)20(21)26-19-16(24-3)6-4-13(18(19)21)12-15(14)22/h4-7,14-15,17,20H,8-12H2,1-3H3/t14?,15?,17-,20?,21-/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
1.82E+3 -32.8n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Cannabinoid receptor 1/Mu-type opioid receptor


(Homo sapiens (Human))
BDBM208994
PNG
(US9233167, a-6-mPEG5-O-Hydroxycodone)
Show SMILES COCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(OC)c5O[C@@H]1[C@]2(CCN3C)c45 |r,TLB:30:38:20:36.34.35,25:24:20:36.34.35|
Show InChI InChI=1/C29H45NO9/c1-30-9-8-28-25-21-4-5-22(33-3)26(25)39-27(28)23(6-7-29(28,31)24(30)20-21)38-19-18-37-17-16-36-15-14-35-13-12-34-11-10-32-2/h4-5,23-24,27,31H,6-20H2,1-3H3/t23-,24?,27-,28-,29+/s2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
1.86E+3 -32.7n/an/an/an/an/an/a25



Nektar Therapeutics

US Patent


Assay Description
Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...


US Patent US9233167 (2016)


BindingDB Entry DOI: 10.7270/Q25T3J97
More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 124 total )  |  Next  |  Last  >>
Jump to: